JACOBS LEVY EQUITY MANAGEMENT, INC

Position in SCLX — Scilex Holding Co

CIK 884414 FLORHAM PARK, NJ

Position in SCLX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$321,071

New position

Shares Held

41,163

first reported quarter

Ownership

0.485%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#4

of 73 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $75,542,759 across 4 Drug Manufacturers - General names. SCLX ranks #4 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	707,023	$40,738,665
2	LLY	ELI LILLY & Co	25,294	$30,338,384
3	MRK	Merck & Co., Inc.	32,254	$4,144,639
4	SCLX	Scilex Holding Co This page	41,163	$321,071

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$321,071	41,163	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.